Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acyl-protein thioesterase 2 (LYPLA2) is an enzyme with hydrolase activity that regulates membrane lipid composition and protein localization by hydrolyzing fatty acids from S-acylated cysteine residues of various proteins, such as certain G protein subunits, HRAS, and GAP43[1][2]. It also acts as a lysophospholipase, catalyzing the removal of acyl groups from lysophospholipids, and participates in the hydrolysis of prostaglandin glycerol esters, implicating it in lipid mediator metabolism and cell signaling[1][2][4]. LYPLA2 plays a crucial role in lipid homeostasis and cellular signaling, and its dysfunction is associated with several neurological and degenerative diseases[1][2][4]. Its paralog, LYPLA1, has overlapping but non-redundant functions.
Inhibitors prevent hydrolysis of fatty acyl moieties from proteins, altering protein localization and function. Modulation of lysophospholipid and prostaglandin metabolism, affecting lipid-mediated signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acyl-protein thioesterase 2 (LYPLA2).